WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2023

Feb 23, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2023-02-21

Reporting Person: MacKay Kimberly Banks (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-21	Common Stock	A	327.00	$306.68	Acquired	637.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-21	Stock Options (Right to buy)	$306.68	A	2988.00	Acquired	2033-02-21	Stock Options (Right to Buy) (2988.00)	Direct

Footnotes

F1: 2020 PSUs (PP19) award vesting net of taxes withheld

F2: This award vests in four equal annual installments beginning on February 21, 2024.